C12N 9/6402
From non-mammals
Official title: {from non-mammals}
C12N9/6402 (From non-mammals) appears on 291 US grants and 377 published applications in this corpus.
Search patents in C12N- Granted patents
- 291
- Published applications
- 377
- Assignees
- 291
- Inventors
- 1,027
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 3 | 0 |
| 1987 | 2 | 0 |
| 1988 | 4 | 0 |
| 1989 | 1 | 0 |
| 1990 | 2 | 0 |
| 1991 | 0 | 0 |
| 1992 | 2 | 0 |
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 2 | 0 |
| 1996 | 1 | 0 |
| 1997 | 7 | 0 |
| 1998 | 16 | 0 |
| 1999 | 14 | 0 |
| 2000 | 12 | 0 |
| 2001 | 15 | 1 |
| 2002 | 13 | 17 |
| 2003 | 10 | 23 |
| 2004 | 3 | 13 |
| 2005 | 6 | 15 |
| 2006 | 4 | 18 |
| 2007 | 10 | 9 |
| 2008 | 5 | 16 |
| 2009 | 9 | 16 |
| 2010 | 13 | 21 |
| 2011 | 16 | 13 |
| 2012 | 13 | 22 |
| 2013 | 9 | 7 |
| 2014 | 10 | 9 |
| 2015 | 4 | 3 |
| 2016 | 10 | 7 |
| 2017 | 4 | 12 |
| 2018 | 4 | 13 |
| 2019 | 9 | 11 |
| 2020 | 9 | 13 |
| 2021 | 8 | 16 |
| 2022 | 10 | 17 |
| 2023 | 3 | 11 |
| 2024 | 10 | 26 |
| 2025 | 6 | 29 |
| 2026 | 7 | 19 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- RNA-guided nuclease15 Sep 2026US 12,735,691 B1Inari Agriculture Technology, Inc.
- Methods of treating paraproteinemic neuropathy with anti-C2 antibodies18 Aug 2026US 12,708,664 B2argenx BV
- Method for increasing the extraction rate of chondroitin sulfate prepared from tilapia skull5 May 2026US 12,618,090 B2Guangdong Ocean University
- Bacillus thuringiensis toxin receptors and uses thereof17 Mar 2026US 12,577,284 B2Monsanto Technology LLC
- Keratinolytic polypeptides and methods of use10 Feb 2026US 12,543,743 B2Cornell University
- Granzyme expressing t cells and methods of use27 Aug 2026US 2026/0248851 A1The Regents of the University of Colorado, a body corporate
- Bi-specific adapters and their use with universal car-t cells in the treatment of tumors and the inhibition of cancer-associated fibroblasts27 Aug 2026US 2026/0248923 A1Purdue Research Foundation
- Modified subtilisin proteins & uses thereof6 Aug 2026US 2026/0226447 A1University of Tennessee Research Foundation
- Bacillus thuringiensis toxin receptors and uses thereof30 Jul 2026US 2026/0217787 A1Monsanto Technology LLC
- Recombinant protease for cell detachment23 Jul 2026US 2026/0209737 A1Novo Nordisk Pharmatech A/S
Most cited
By later US patents
- Subtilisin variants87US 6,902,922 B2Maxygen, Inc. · 2005
- Subtilisin variants73US 7,220,566 B2Maxygen, Inc. · 2007
- Sushi peptide multimer73US 7,763,704 B2National University of Singapore · 2010
- Process for preparing anti-obesity protein71US 5,614,379 AEli Lilly and Company · 1997
- Methods for treating conditions associated with MASP-2 dependent complement activation60US 7,919,094 B2Omeros Corporation · 2011